Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public

Isao Saito1, Kazumasa Yamagishi2, Yoshihiro Kokubo3

  • 1Department of Public Health and Epidemiology, Faculty of Medicine, Oita University.

Insights

Lower non-HDL cholesterol is linked to reduced large-artery stroke but increased intracerebral hemorrhage risk in Japanese men. This contrasts with established links to coronary heart disease.

Area of Science:

  • Cardiovascular epidemiology
  • Biomarkers and disease risk

Background:

  • Non-high-density lipoprotein cholesterol (non-HDL-C) is a known risk factor for coronary heart disease (CHD).
  • The association between non-HDL-C and specific stroke subtypes remains underexplored.

Purpose of the Study:

  • To investigate the relationship between non-HDL-C levels and the risk of different stroke subtypes.
  • To determine sex-specific associations of non-HDL-C with stroke and CHD.

Main Methods:

  • A prospective study of 30,554 Japanese adults (40-69 years) without prior cardiovascular disease.
  • Cox proportional hazard models were used to estimate sex-specific hazard ratios for stroke subtypes and CHD across non-HDL-C quintiles, adjusting for risk factors.

Main Results:

  • A U-shaped association between non-HDL-C and overall stroke risk was observed in men.
  • In men, lower non-HDL-C was inversely associated with intracerebral hemorrhage (ICH), especially lobar ICH, but positively associated with large-artery occlusive infarction.
  • Non-HDL-C showed a positive association with CHD in both sexes.

Conclusions:

  • In Japanese men, very low non-HDL-C levels are associated with an increased risk of intracerebral hemorrhage.
  • Conversely, higher non-HDL-C levels in men are linked to a greater risk of large-artery occlusive infarction.
  • These findings highlight differential associations of non-HDL-C with stroke subtypes, distinct from its established role in CHD.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
561
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
401
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
592
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
334